Genentech is a healthcare company focusing on biotechnology, pharmaceuticals, and research. Established in 1976 by Robert Swanson and Herbert Boyer, the South San Francisco-based firm discovers, develops, manufactures, and commercializes medicines for patients with serious or life-threatening medical conditions. With a diverse range of products on the market and a robust development pipeline, Genentech has been a member of the Roche Group since 2009, where it operates as an independent center.
The company has an employee base of 13,638 diverse individuals and an annual revenue of $166.9 million. With a strong focus on both research and early development, Genentech's South San Francisco campus serves as the headquarters for Roche's pharmaceutical operations in the United States. With the leadership of Genentech’s CEO Alexander Hardy, its employees enjoy working in a diverse workplace with an average salary of $97,473 per year.